NEW YORK, July 29, 2015 /PRNewswire/ -- Therapath Neuropathology (www.Therapath.com), a leader in neuropathology testing, announces increased partnerships with VA and Military Medical centers both domestically and worldwide. Therapath offers Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD) for the diagnosis of small fiber neuropathy (https://therapath.com/skin).
Demonstration of a reduction in the Epidermal Nerve Fiber Density (ENFD) on punch skin biopsy is a highly sensitive and specific test for Small Fiber Neuropathy (SFN). (Periquet et al, 1999; Ebenezer et al, 2007; Lauria et al, 2010; Hays et al, 2010).
- Recent findings report a connection between undiagnosed small fiber neuropathy and Gulf War Illness https://www.youtube.com/watch?v=pZP54Q55jN8.
VA and Military Health Systems can order a free skin biopsy test kit online: https://www.therapath.com/order/veterans-administration-military-health-system
Therapath is active in SAMS System | DUNS # 623108151 | CAGE code: 4CB. Therapath participates with Tricare, accepts government purchase card, and is available to participate in the regional contracting process, when requested.
About Therapath Neuropathology:
Therapath Neuropathology, founded in 2004, is a College of American Pathology accredited (CAP) and CLIA licensed specialized laboratory. The medical team is board certified in neuropathology https://therapath.com/about/medical-and-scientific-team, academically trained and extensively published.
Therapath's focus is on research and development in the testing services for muscle biopsy, nerve biopsy with teased fiber analysis, ocular (including optic neuritis), skin epidermal nerve fiber density, sweat gland nerve fiber density, skin biopsy for CADASIL and other storage disorders as well as brain/spinal cord specimens.
Therapath serves hospitals, private practitioners, reference laboratories, pharmaceutical industry, and researchers throughout all 50 states and worldwide.
SOURCE Therapath Neuropathology